Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
考察SM03单药治疗滤泡型非霍奇金淋巴瘤患者的疗效和安全性。
CTR20131130Phase 2Completed
- Sponsor
- Longrui Pharmaceutical
- Start
- Jan 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of suciraslimab in follicular lymphoma (FL), sponsored by Longrui Pharmaceutical. Started Jan 2015; status: completed.
02
Drugs
suciraslimab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on CTR20131130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131130.